Understanding abnormalities in vascular specification and remodeling

Pediatrics

Volumn 116, Issue 1, 2005, Pages 228-230

  Enciso, Josephine M ^a,b   Hirschi, Karen K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; EPHRIN B2; EPHRIN RECEPTOR B4; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR B; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; FIBROBLAST GROWTH FACTOR 2; SCLEROPROTEIN;

ANGIOGENESIS; BLOOD VESSEL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; MORPHOGENESIS; NOTE; PRIORITY JOURNAL; URINE LEVEL; VASCULAR DISEASE; ANIMAL; CHILD; CONGENITAL MALFORMATION; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; URINE; VASCULAR TUMOR;

ANIMALS; BLOOD VESSELS; CHILD; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR NEOPLASMS;

EID: 33644623147     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0132     Document Type: Note

References (16)

1. Marler JJ, Fishman SJ, Kilroy SM, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005;116:38-45
2. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674
3. Torres-Vazquez J, Kamei M, Weinstein BM. Molecular distinction between arteries and veins. Cell Tissue Res. 2003;314:43-59
4. le Noble F, Moyon D, Pardanaud L, et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development. 2004;131:361-375
5. Hacking WJ, VanBavel E, Spaan JA. Shear stress is not sufficient to control growth of vascular networks: a model study. Am J Physiol. 1996;270(1 pt 2):H364-H375
6. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-β, and heterotypic cell-cell interactions mediate the recruitment and differentiation of 10T2/3 cells to a smooth muscle cell fate [published correction appears in J Cell Biol. 1998;141:1287]. J Cell Biol. 1998;141:805-814
7. Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171-1180
8. Vikkula M, Boon LM, Carraway KL 3rd, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87:1181-1190
9. Hungerford JE, Owens GK, Argraves WS, et al. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol. 1996;178:375-392
10. Hirschi KK, Burt JM, Hirschi KD, et al. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ Res. 2003;93:429-437
11. van den Driesche S, Mummery CL, Westermann CJ. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor β signaling in vasculogenesis and angiogenesis. Cardiovasc Res. 2003;58:20-31
12. Bohnsack BL, Lai L, Dolle P, et al. Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation. Genes Dev. 2004;18:1345-1358
13. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516
14. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science. 1990;248:1408-1410
15. Oh J, Takahashi R, Adachi E, et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene. 2004;23:5041-5048
16. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789-800